Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Investing as Shakespearean Tragedy: The Story of Ariad Pharmaceutical (ARIA)

By  +Follow November 12, 2013 8:57AM
Tickers Mentioned:

Shares in Ariad Pharmaceuticals (ARIA) were up 10.78 percent on Veterans Day. Even for a small-cap like Ariad, coming in at a valuation just under a half billion dollars, that’s normally what one would consider a pretty solid bounce. That’s a day that, for a lot of investors, would stand out. However, for the battered shareholders of Ariad, it probably doesn’t even register any more. Okay, that’s not true, double-digit jumps always register. But after the Odyssey Ariad’s been on for the last month, it’s not difficult to imagine that days like Monday just get lost in the shuffle.

It’s not often you see a company go on a ride like Ariad just has, plunging sharply, appearing to rally, rinse and repeat. And it’s a drama that’s swept a lot of people up. Over the last 3 months, Ariad’s moved an average of 11.14 million shares a day, good to make it the 75th most traded security over that period, one spot behind Elon Musk’s Tesla Motors (TSLA) , a battleground stock and the source of general market fascination. That’s a class that contains mostly mega-cap blue chips and high-profile ETFS, relatively few small-cap companies. And that’s not even the whole story. Ariad’s heavy volume is drawn mostly from the massive spike this last month. Over the last 30 days Aria has been moving an average of 20 million shares a day, meaning that more than 10 percent of outstanding shares are trading hands on an average day.

So what’s happening with this company? The story’s a simple one, but, for Ariad investors, it’s a tragic one.

Volatile Month

Lets start with the whole story: since the start of October, Ariad Pharmaceutical’s stock has lost over 85 percent of its value. No matter how specifically you pull things apart, that’s the simple fact one cannot avoid. Especially if you’ve owned Ariad for that whole stretch. But inside that one big sell-off is a series of daily price moves that could drive an investor insane. Here’s a timeline or the events that have brought Ariad so much grief:

October 8:

After market close, news gets out regarding the clinical trials for Ariad’s leukemia drug Iclusig and it’s bad. In fact, if you’re long Ariad, it’s positively awful. The drug showed blood clots developing in 11.8 percent of people treated with Iclusig after 24 months. This was a big jump from the 8 percent rate found after 11 months, and it prompts the FDA to block Ariad from enrolling any new patients to drug trials for Iclusig.

Like most small-cap pharma companies, Ariad’s future is tied mainly to just a couple of drugs, and the news that one of them might not be safe is pretty drastic. Especially when one considers that the nearly 800 percent gains from the start of 2010 to October 7 had a lot to do with the fact that Iclusig looked so promising, even getting accelerated approval based on its Phase 2 clinical data.

So it shouldn’t be surprising that the market’s reaction was swift and vengeful. As soon as investors got a crack at selling their position on October 9 shares plummeted over 65 percent.

October 10-18:

If the story ended there, it would be pretty much in line with a familiar narrative: small-cap pharma plummets on negative results of clinical trial. But, while nothing matched the degree of the move on the ninth, Ariad kept trading at heavy volumes and kept posting double-digit moves.

A series of analyst downgrades hit the company on October 10, with Barclays (BCS) downgrading the stock from overweight to underweight and cutting the price target from $25 a share to $4 (ouch). The stock kept falling, losing another 30 percent from October 10-16 but coasting into what appeared to be a bottom on October 16.

Then, on October 17, signs of life! Following comments from JP Morgan (JPM) analyst Cory Kasimov that physicians may not be all that concerned about the blood clots, the stock rebounded, posting a 10.78 percent gain and potentially giving hope to Ariad owners that the worst was behind them.

Except that it wasn’t. Not at all. October 18, word came out that Ariad and the FDA had agreed to halt testing of Iclusig entirely based on the rate of blood clotting incidences. The discontinuation of the late-stage trial dubbed Epic by Ariad caused shares to plunge more than 40 percent that day.

October 21-October 30:

After any stock gets hammered that hard in that short a period, one might expect it to bounce back. At least a little. Considering how steep the discount it’s trading at as compared to a mere two weeks ago, it has to garner at least a little interest, right?

And it did. The company staged a pretty substantial rally, gaining almost 50 percent in just nine days. It’s not much when one considers just how fall the stock fell prior to the rally, but at least the battered shareholders got a respite in the end, right?

October 31:

Only it wasn’t the end. Halloween was extra spooky if you had decided to wait out Ariad’s steep decline. Ariad announced that it would suspend marketing and distribution of Iclusig while it "continues to negotiate updates to the U.S. prescribing information." In retrospect, it certainly seems as though this shouldn’t have been all that surprised, but it clearly surprised at least some people as the company’s stock plunged nearly 45 percent.

And Beyond…?

Where Ariad’s going from here is unclear. Since the start of November, the stock’s up over 15 percent, including a 17.27 percent leap the day after Halloween and Monday’s double-digit gain. However, precisely what to expect moving forward is unclear. In the event that Ariad can return Iclusig to the market and ensure that it’s safe, there’s a pretty good chance the stock takes off. That said, there’s no real way to know whether or not that’s possible. In the meantime, the company announced that it was shedding 40 percent of its American-based workforce on November 7.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for ARIA
24 Nov 15 18:02:20
Wondering about risks of $ARIA? The 63-day volatility is 51.59% https://t.co/mP9DUNzG7T
24 Nov 15 17:43:33
PACB Pacific Biosciences of California Inc. Bid Size https://t.co/9LCtTeVVDO $PACB $AEM.TO $ARIA $MMM #PACB #pennystocks #invest
IH News Desk
24 Nov 15 17:35:04
COP ConocoPhillips Filings https://t.co/gUiSpBk9nX $COP $IYR $KBIO $ARIA #COP #invest #invest
24 Nov 15 17:34:33
CEF Central Fund of Canada Ltd. Company Info https://t.co/Eb8h8f5sGo $CEF $UA $XLI $ARIA #CEF #invest #nasdaq
24 Nov 15 17:33:33
ARIA ARIAD Pharmaceuticals, Inc. Ask https://t.co/HNxtwzgIUn $ARIA $MYEC $DBC $SQQQ #ARIA #stockmarket #share
24 Nov 15 17:33:09
AA Alcoa, Inc. Ideas https://t.co/W3q7ctIGc9 $AA $TAN $ARIA $PFE #AA #finance #invest
Greg David
24 Nov 15 17:19:37
24 Nov 15 17:17:26
24 Nov 15 16:56:19
Do you know that #WallStreet price for $ARIA is $8.08 https://t.co/hynhrlID8H
24 Nov 15 16:51:18
Unicorn Bay rating for $ARIA is 2.77 out of 5. https://t.co/Zn1sCmOLLS
24 Nov 15 16:38:19
We calculated 63-day Expected Return of $ARIA for you: 12.4% https://t.co/GSxZ775uLA
24 Nov 15 16:01:21
Not sure what to do with $ARIA? Explore our #fundamental pros and cons. https://t.co/E3Bb4Oskc8
Penny Stockington
24 Nov 15 15:51:37
$GEQU Has Increased Almost 20 TIMES In Value, For Our Subscribers! Huge News: https://t.co/viouXok21i $FASC $ARIA $TUCN
Stock Rocket
24 Nov 15 15:37:27
Our Platinum Members Have Been Seeing MASSIVE Gains On Our Penny Stock Picks! Subscribe Today: https://t.co/ro7o3SYbd1 $FASC $ARIA $TUCN
DE Asset Management
24 Nov 15 15:37:24
RT @DailyStockPlays: Stochastic Oversold https://t.co/9RjQNe4K0i $RCL $TVIX $UVXY $STNG $ZBH $SPXS $GS $AAL $CTL $ASML $ARIA $CRK $EXEL $SP…
24 Nov 15 15:36:28
Our Pick On $HCTI More Than Tripled For Our Members, In 3 Weeks! Subscribe For Our New Picks: https://t.co/6sqzAAvjDY $FASC $ARIA $TUCN
24 Nov 15 15:34:25
Our Stock Alerts Gained Over 1,900% In 2 And A Half Months! See Our Special New Pick: https://t.co/rdhi4T4cqG $FASC $ARIA $TUCN
Stock Dawgzz
24 Nov 15 15:34:18
Our Stock Alerts Have Been Seeing Record Gains! Our New Pick Will Be MASSIVE: https://t.co/DXRm9DTWiK $FASC $ARIA $TUCN
24 Nov 15 15:27:01
Stochastic Oversold https://t.co/9RjQNe4K0i $RCL $TVIX $UVXY $STNG $ZBH $SPXS $GS $AAL $CTL $ASML $ARIA $CRK $EXEL $SPXU $SDS $CVEO $ZIOP
Britney Salvato
24 Nov 15 14:15:47
JD Direxion Daily Junior Gold Miners Index Bear 3X Shares Market Cap https://t.co/30GSlNQoGX $JD $BIDU $ARIA $NFLX #JD #stocks…
Sarcasm Bot
24 Nov 15 14:06:54
$ARIA they like to eat chicken feet. I am not sure whether their yellow skin color is a significant factor.
Britney Salvato
24 Nov 15 13:54:56
RT @newswelldone: $ARIA $MOS: Downturn of Stocks: Ariad Pharmaceuticals, (NASDAQ:ARIA …: https://t.co/lhBiD6w7UY
BNK Invest
24 Nov 15 13:28:05
Noteworthy Tuesday Option Activity: $CLVS $ARIA $AJRD #stockoptions https://t.co/SDygdZ3txQ
donald coontz
24 Nov 15 13:02:45
ARIA ARIAD Pharmaceuticals, Inc. Day High https://t.co/wsC7YHzlnK $ARIA $PCY $SLV $EEM #ARIA #share #tradeideas
24 Nov 15 12:24:03
https://t.co/Lh08gvSEBL #stocks large players are selling $ARIA $FCE.A $BKD
Venessa Forster
24 Nov 15 12:20:49
RT @IHNASDAQOMX: BX Blackstone Group LP Chart https://t.co/28e4k0qLYF $BX $ARIA $UPRO $INSM #BX #invest #pennystocks
ione tietjen
24 Nov 15 10:48:56
$ARIA: Company Shares of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA …: https://t.co/89I2Yk6MZp
PennyStock Zone
24 Nov 15 10:15:30
Connor Bruggeman SchoolTrader interview reveals some of his strategy! https://t.co/DgrNThhkJM $ARIA $BBRY $DSKY $SGEN $XONE
Honey Adrian
24 Nov 15 10:07:46
JPM J.P. Morgan Chase & Co. 52Wk High https://t.co/xHi9mTeh3C $JPM $ARIA $XOM $VRSN #JPM #share #stocks
nakisha snoots
24 Nov 15 08:36:42
RT @OTCtraderDave: https://t.co/APzP66vnr4 IN PLAY: $ARIA $BGNN $ASTI $HMY $CRC $MYEC $GEQU $ARNA $CDE $CLF $ON $EGO $BAS $RMCP
Lucy Donovan
24 Nov 15 07:54:43
Ariad Pharmaceuticals Stock Price Down 3.3% $ARIA https://t.co/3el6OGqxUo
Stocks Yard
24 Nov 15 07:16:48
This Service Made 20,000% Gains In the Last Month! Subscribe Here https://t.co/mMfpDfnDem .. $FASC $ARIA $TUCN
Breaking News
24 Nov 15 05:29:10
$ARIA $ZIOP $CTIC: Small cap stock picking: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA …: https://t.co/9I4lV9FqP5
darcey underdown
24 Nov 15 05:28:43
Ryan Carson
24 Nov 15 05:28:08
$ARIA No one is covering Ariad anymore. Makes no sense with the ongoing '113 progress.. #Forgotten
24 Nov 15 04:49:33
USO United States Oil Fund, LP Bid Size https://t.co/UHC96yn0xY $USO $LNKD $ARIA $INTC #USO #invest #stockmarket
24 Nov 15 04:47:30
SQQQ ProShares UltraPro Short QQQ % Change https://t.co/kV30peEwH3 $SQQQ $P $SUNE $ARIA #SQQQ #stocks #tradeideas
24 Nov 15 04:33:34
ARIA ARIAD Pharmaceuticals, Inc. E.P.S. https://t.co/p6zDf4W3d3 $ARIA $MANH $LDL $FM #ARIA #stock #nasdaq
Investors Hangout
24 Nov 15 04:33:08
AEZS AEterna Zentaris Inc. Prev Close https://t.co/c211bZ0V0R $AEZS $BRK/B $ARIA $NEM #AEZS #tradeideas #pennystocks
24 Nov 15 03:48:38
SCO ProShares UltraShort DJ-UBS Crude Oil Summary https://t.co/mtdSYH5LLs $SCO $FB $ARIA $BRWC #SCO #investing #… https://t.co/pXsOmdBcSm
IH News Desk
24 Nov 15 03:46:03
SCO ProShares UltraShort DJ-UBS Crude Oil Summary https://t.co/kR1d6Hqpau $SCO $FB $ARIA $BRWC #SCO #investing #stock
Cute kittens
24 Nov 15 03:39:05
CAT Caterpillar, Inc. Ask Size https://t.co/HVAhgibo60 $CAT $ARIA $PCY $VMW #CAT #invest #share
24 Nov 15 03:36:08
CMCSA Comcast Corp. Open https://t.co/hD9KyI1ddr $CMCSA $ARIA $XLY $BAC #CMCSA #nasdaq #nasdaq
Investors Hangout
24 Nov 15 03:36:05
CAT Caterpillar, Inc. Ask Size https://t.co/UEs2rXOmjr $CAT $ARIA $PCY $VMW #CAT #invest #share
24 Nov 15 03:34:11
ARIA ARIAD Pharmaceuticals, Inc. Day High https://t.co/VnJJ4y3DW5 $ARIA $PCY $SLV $EEM #ARIA #share #tradeideas
Michael Cook
23 Nov 15 20:25:31
After 3,500% Gains In 4 Months We Have A New Stock Pick Coming Tomorrow! Check It Out: https://t.co/A6O2grVwS8 $FASC $ARIA $TUCN
Paul Henry
23 Nov 15 20:23:42
Major News From $BMXC Announcing A Quarter Million Dollar Order And $73,500 In Online Sales: https://t.co/oq58ZZVeAT $FASC $ARIA $TUCN
Michael James
23 Nov 15 20:23:39
$BMXC Gained Over 1,000% In The Past Week And A Half! Major Update: https://t.co/FFcwX6mYwm $FASC $ARIA $TUCN
IH News Desk
23 Nov 15 19:51:05
VWESX Vanguard Long-Term Corporate Fund % Change https://t.co/vyzXaxvzWE $VWESX $XLK $ARIA $GDX #VWESX #stocks #stocks
Binary Trader Pro
23 Nov 15 19:51:00
RT https://t.co/mSmp6pYX4f RT DennyT14: JPM J.P. Morgan Chase & Co. 52Wk High https://t.co/18b5ffyuIv $JPM $ARIA $XOM $VRSN #JPM #share …
By  +Follow November 12, 2013 8:57AM



blog comments powered by Disqus

 Today's Must Reads

What Crowdfunding Leaders Are Saying About the SEC’s Approval of Title III

How the Drug Price Scrutiny is Affecting Pharma Stocks

8 More Tips for Choosing the Right Crowdfunding Platform

Will the Post-Smartphone Era Bring Wearable Drones?

3 Cloud Stocks That Pay Dividends


Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register